Today: 7 February 2026
Subscribe

Boeing stock edges higher on Alaska’s 110-jet order, but MAX 10 approval is the next hurdle

Boeing stock edges higher on Alaska’s 110-jet order, but MAX 10 approval is the next hurdle

New York, Jan 7, 2026, 12:40 EST — Regular session Boeing stock rose modestly on Wednesday after Alaska Air Group placed its biggest-ever aircraft order with the planemaker. Shares were up 0.4% at $230.78, after climbing nearly 2% earlier in the session. Reuters The order lands as Boeing tries to lift jet output under close U.S. regulatory scrutiny. The Federal Aviation Administration approved Boeing to raise 737 MAX production to 42 a month in October, ending a cap imposed after a January 2024 mid-air panel blowout on a MAX 9. Reuters It also drags attention back to the 737 MAX
7 January 2026
··
Workiva stock jumps 5% in regular trade as WK eyes jobs data, CFO switch

Workiva stock jumps 5% in regular trade as WK eyes jobs data, CFO switch

NEW YORK, January 7, 2026, 12:41 ET — Regular session Workiva Inc shares were up about 5.5% at $91.40 on Wednesday, after touching $92.10 earlier in the session. The stock has traded between $86.29 and $92.10 so far, with about 458,000 shares changing hands. The move came as U.S. stocks chopped around after data showed job openings fell more than expected in November, while private payrolls rose less than expected in December. “No one wants to make any outsized bets,” said Kim Forrest, chief investment officer at Bokeh Capital Partners, with investors looking ahead to Friday’s U.S. jobs report. There
7 January 2026
·
Morgan Stanley’s Bitcoin and Solana ETF filings drag a big U.S. bank deeper into crypto

Morgan Stanley’s Bitcoin and Solana ETF filings drag a big U.S. bank deeper into crypto

NEW YORK, January 7, 2026, 12:39 (EST) Morgan Stanley Investment Management has filed initial registration statements for two crypto-linked exchange-traded products — the Morgan Stanley Bitcoin Trust and the Morgan Stanley Solana Trust — and said the securities cannot be sold until the filings become effective. Morgan Stanley The move would be the first attempt by a major U.S. bank to bring in-house crypto ETFs to market at a time when Washington’s stance has turned more permissive and traditional finance firms are looking for cleaner ways to package exposure. “It’s interesting to see Morgan Stanley move into a commoditized market,” said
7 January 2026
···
China tells tech firms to pause Nvidia H200 orders — Beijing weighs homegrown AI chips

China tells tech firms to pause Nvidia H200 orders — Beijing weighs homegrown AI chips

BEIJING, Jan 8, 2026, 01:47 (GMT+8) Chinese authorities have told some tech firms to stop placing new orders for Nvidia’s H200 artificial-intelligence chips this week, the Information reported, as Beijing weighs whether to let the processors into the country. The move appears aimed at stopping companies from rushing to stockpile U.S. chips before officials settle on rules, and could be followed by a push to buy domestic AI processors instead, the report said. “China is committed to basing its national development on its own strengths,” Liu Pengyu, a spokesperson for the Chinese Embassy in the United States, said. Reuters The pause
7 January 2026
···
Robinhood stock slips after CEO’s sale filing; HOOD in focus ahead of Feb. 10 earnings

Robinhood stock slips after CEO’s sale filing; HOOD in focus ahead of Feb. 10 earnings

New York, Jan 7, 2026, 12:41 EST — Regular session Robinhood Markets Inc (HOOD.O) shares fell 2.1% to $119.14 in midday trading on Wednesday after a filing showed Chief Executive Vladimir Tenev planned to sell up to 375,000 shares, worth about $43.2 million, through Morgan Stanley Smith Barney. The stock traded between $117.61 and $121.95. SEC The move matters because Robinhood has become a crowded trade after a strong run: its shares nearly tripled in 2025, Reuters Breakingviews reported, putting more weight on insider transactions and small shifts in expectations. Reuters Form 144 is a notice insiders file ahead of
7 January 2026
··
Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

New York, January 7, 2026, 12:25 (EST) — Regular session Shares of Adaptive Biotechnologies rose 6.5% to $17.15 on Wednesday, after trading between $16.24 and $17.33, giving the company a market value of about $2.0 billion. The stock has traded between $4.32 and $21.89 over the past 52 weeks. The move matters now because investors have been bidding up riskier biotech names again, and ADPT tends to swing with that tone. The SPDR S&P Biotech ETF and the iShares Nasdaq Biotechnology ETF were each up about 2.5% in midday trade. The broader market was also higher, but not by as
7 January 2026
··
AST SpaceMobile stock slides after Scotiabank downgrade calls valuation “irrational”

AST SpaceMobile stock slides after Scotiabank downgrade calls valuation “irrational”

New York, Jan 7, 2026, 12:42 (EST) — Regular session AST SpaceMobile, Inc. (ASTS) fell 8.5% to $89.18 in midday trading on Wednesday after Scotiabank cut the satellite communications company to sector underperform. The stock opened at $91 and hit a session low of $88.49 as volume rose past 12.3 million shares. The downgrade hits after a sharp run that has pushed the stock close to its highs and made valuation the central argument. Shares have more than tripled over the past 12 months, even though the company is not expected to post positive operating profit until 2027. Barron’s Scotiabank
7 January 2026
·
Vedanta hits fresh 52-week high near Rs 630 on demerger trade; broker targets stretch to Rs 686

Vedanta hits fresh 52-week high near Rs 630 on demerger trade; broker targets stretch to Rs 686

MUMBAI, January 7, 2026, 23:15 (IST) Vedanta Ltd shares touched a 52-week high of 629.90 rupees on Wednesday before giving back most of the move, ending almost flat at 622 rupees. Business Today The jump mattered because it came in a choppy session for Indian stocks, with investors scanning trade and geopolitical headlines ahead of the earnings season. “Markets remain sensitive to trade and geopolitical developments,” said Hitesh Tailor, a research analyst at Choice Equity Broking. Reuters Brokerage targets have moved up as the rally has stretched into a month-long run. Kotak Securities has a target of 650 rupees, Investec
7 January 2026
·
CMB.Tech NV stock closes up 4% in Brussels — dividend timing, “freeze period” and next dates in focus

CMB.Tech NV stock closes up 4% in Brussels — dividend timing, “freeze period” and next dates in focus

BRUSSELS, Jan 7, 2026, 18:20 CET — Market closed CMB.Tech NV shares closed up 4.1% at 8.89 euros in Brussels on Wednesday, taking their gain over the past five sessions to about 9.6%. The stock finished near a one-week high after the shipping group flagged the trading and payment timetable for an interim dividend. MarketScreener The dates matter now because the record date — when share ownership is checked for dividend eligibility — falls on Wednesday for the Brussels and New York lines, while the company has also imposed a short “freeze period” that temporarily blocks share repositioning between registers.
7 January 2026
·
Legend Biotech (LEGN) stock jumps after Oppenheimer starts coverage with $75 target

Legend Biotech (LEGN) stock jumps after Oppenheimer starts coverage with $75 target

New York, January 7, 2026, 12:32 (EST) — Regular session Shares of Legend Biotech Corp rose 7.4% to $22.53 in midday trading on Wednesday after Oppenheimer initiated coverage with an “Outperform” rating and set a $75 price target, according to MarketBeat. StreetInsider said Oppenheimer analyst Trevor Allred authored the initiation note. MarketBeat Why it matters now: Legend’s stock has been under pressure and touched a 52-week low of $21.16 earlier this week, keeping investors sensitive to any shift in the narrative around its lead product, Carvykti. Carvykti is a CAR‑T therapy — a personalized cancer treatment that uses a patient’s
7 January 2026
·
Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

New York, Jan 7, 2026, 12:23 (EST) — Regular session Mastercard Incorporated (NYSE:MA) shares rose 0.7% to $584.60 on Wednesday, after trading between $577.52 and $584.60. About 1.36 million shares had changed hands by late morning. The move came in a mixed session for U.S. stocks. The S&P 500-tracking SPY was up about 0.3% while the Dow-linked DIA slipped 0.1%; tech-heavy QQQ gained about 0.7%. Labor data kept risk appetite in check ahead of Friday’s government jobs report. U.S. private payrolls rose 41,000 in December, below economists’ forecasts, ADP data showed. Morgan Stanley kept Mastercard rated “overweight” — a call
7 January 2026
·
Nokia stock jumps in New York after Kepler flips to “buy” as earnings loom

Nokia stock jumps in New York after Kepler flips to “buy” as earnings loom

NEW YORK, Jan 7, 2026, 12:25 EST — Regular session Nokia Oyj’s U.S.-listed shares climbed 5.9% to $6.86 in midday trade on Wednesday after Kepler Cheuvreux upgraded the Finnish telecom equipment maker to “buy,” according to StreetInsider. StreetInsider.com The call landed after a roughly 15% pullback from recent highs, which Kepler said had opened a better entry point. The broker raised its target price to 6.60 euros from 5 euros and called Nokia’s valuation “rather reasonable” at about 13 times its 2026 estimated EBIT — earnings before interest and taxes. Investing.com That matters now because Nokia is heading into its
7 January 2026
··
1 … 862 863 864 865 866 … 2,716

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop